Search research articles
Contact Us
Filters
Showing results (141-150 of 202) with videos related to
Page
of 21
Sort By:
Bioinformatics (Oxford, England)
|
November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic models
Yannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Therapeutic Advances in Medical Oncology
|
November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up
Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Virchows Archiv : an International Journal of Pathology
|
June 6, 2022
MCL1 as putative target in pancreatoblastoma
Timm M Reissig, Sebastian Uhrig, Philipp J Jost, et al.
Cell Reports
|
June 3, 2014
XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation
Monica Yabal, Nicole Müller, Heiko Adler, et al.
Leukemia
|
July 9, 2015
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
S Jilg, V Reidel, C Müller-Thomas, et al.
International Journal of Cancer
|
March 19, 2019
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
Stefanie Jilg, Michael Rassner, Jacqueline Maier, et al.
Blood
|
February 6, 2014
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner
W Wei-Lynn Wong, James E Vince, Najoua Lalaoui, et al.
ESMO Open
|
April 5, 2025
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy
A C Chiang, M E Olmedo Garcia, J W Carlisle, et al.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group
V Joly, M Moroni, E Concia, et al.
Transplantation Proceedings
|
December 1, 1996
A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group
P U Massari, S Grosso, G de Boccardo, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 202) with videos related to
Sort By:
Page
of 21
Bioinformatics (Oxford, England)
|
November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic models
Yannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Therapeutic Advances in Medical Oncology
|
November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up
Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Virchows Archiv : an International Journal of Pathology
|
June 6, 2022
MCL1 as putative target in pancreatoblastoma
Timm M Reissig, Sebastian Uhrig, Philipp J Jost, et al.
Cell Reports
|
June 3, 2014
XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation
Monica Yabal, Nicole Müller, Heiko Adler, et al.
Leukemia
|
July 9, 2015
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
S Jilg, V Reidel, C Müller-Thomas, et al.
International Journal of Cancer
|
March 19, 2019
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)
Stefanie Jilg, Michael Rassner, Jacqueline Maier, et al.
Blood
|
February 6, 2014
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner
W Wei-Lynn Wong, James E Vince, Najoua Lalaoui, et al.
ESMO Open
|
April 5, 2025
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy
A C Chiang, M E Olmedo Garcia, J W Carlisle, et al.
Antimicrobial Agents and Chemotherapy
|
October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group
V Joly, M Moroni, E Concia, et al.
Transplantation Proceedings
|
December 1, 1996
A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group
P U Massari, S Grosso, G de Boccardo, et al.
Page
of 21